ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 181 filers reported holding ADMA BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,067 | +5322.7% | 363,742 | +3084.6% | 0.02% | – |
| Q1 2024 | $75 | -82.2% | 11,422 | -87.7% | 0.00% | -100.0% |
| Q4 2023 | $421 | +547.7% | 93,236 | +417.3% | 0.00% | +300.0% |
| Q3 2023 | $65 | -66.5% | 18,023 | -69.2% | 0.00% | -50.0% |
| Q1 2023 | $194 | +71.7% | 58,507 | +100.5% | 0.00% | +100.0% |
| Q4 2022 | $113 | -100.0% | 29,180 | -79.5% | 0.00% | -75.0% |
| Q3 2022 | $346,000 | +276.1% | 142,471 | +206.9% | 0.00% | +300.0% |
| Q2 2022 | $92,000 | +178.8% | 46,423 | +144.7% | 0.00% | – |
| Q1 2021 | $33,000 | -26.7% | 18,968 | -18.3% | 0.00% | – |
| Q4 2020 | $45,000 | -87.0% | 23,210 | -80.4% | 0.00% | -100.0% |
| Q2 2020 | $346,000 | -4.4% | 118,200 | -6.0% | 0.00% | 0.0% |
| Q1 2020 | $362,000 | – | 125,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 883,214 | $1,722,000 | 0.80% |
| Telemetry Investments, L.L.C. | 200,615 | $391,000 | 0.66% |
| Perceptive Advisors | 16,584,802 | $32,340,000 | 0.35% |
| Consonance Capital Management LP | 1,558,290 | $3,039,000 | 0.28% |
| 683 Capital Management, LLC | 2,000,000 | $3,900,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 627,931 | $1,224,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 327,052 | $638,000 | 0.10% |
| APOGEM CAPITAL LLC | 54,240 | $106,000 | 0.07% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 82,000 | $160,000 | 0.04% |
| J. Goldman & Co LP | 376,319 | $734,000 | 0.04% |